cis-regulatory elements such as promoters and enhancers (see Tak and Farnham[6] for 63 a comprehensive review). These functional GWAS indicate that for common disease, 64 the majority of associated SNPs reside in non-coding, regulatory regions [5, 7, 8] . One 65 drawback of these methods is that the actual impact of the variant on regulatory 66 elements is not assessed and thus not taken into account for the annotation, which 67 does not go beyond positional overlap. For example, two SNPs that localize to the same 68 chromatin immunoprecipitation with massively parallel sequencing[9] (ChIP-seq) peakof a TF might have opposing effects or no effects at all. To try to resolve this, in silico 70 approaches predicting disruption of transcription factor binding motifs [10, 11] have been 71 used, however, our understanding of actual binding based on known motifs is still 72 limited. Given the fact that classical GWAS thus test many variants that are highly 73 unlikely to be functionally relevant, methods integrating functional knowledge of SNP 74 into GWAS could not only allow prioritize relevant variants but also to increase power 75 for such association studies that now often need tens of thousands of cases for robust 76 signals [1] . 77 annotation is superior to pure overlap methods as it computes allele-specific differences 87 in the effects on these regulatory elements and thus discerns SNPs with functional 88 impact, at least in the given cell lines, from those just residing within the annotated 89 element. Furthermore, it allows incorporating cell-type specific regulatory effects of such 90 variants, adding another critical layer to understand disease mechanisms that are often 91 tissue-specific. 92
93
In this manuscript we present a conceptually new approach fusing classical and 94 functional GWAS. We obtain regulatory information on SNPs by generating sets of 95 SNPs in "functional units" using deep learning and then performing functional unit-Wide 96
Association Studies (deepWAS). First, we extracted DNA sequences centred on a SNP 97 to predict close to 1000 allele-specific regulatory effects of chromatin features in various 98 cell types (a pair of one chromatin feature in one cell type is further called "functional 99
unit") using DeepSEA [12] . Second, the resulting significant regulatory SNPs were then 100 used to identify sets of SNPs characterized by their joint moderation of a functional unit. 101
Finally, we identify regulatory SNPs, short "deepSNPs", each coupled to a functional 102 unit by associating each set of predicted regulatory SNPs with a trait or disease. To that 103 end we use a multiple regression model with SNP selection using L1 ("LASSO") 104 penalization [15] . By testing regulatory SNPs within each of the confined functional units, 105
we controlled not only for correlations induced by LD but also for possible joint, thereby 106 again correlated, SNP effects on two or more chromatin features or cell types for which 107 LASSO would select one representative SNP. This optimized variant selection improves 108 our power to identify SNPs that may play a role in the etiology of the disease. 109
110
For a proof of concept, we used data from a published GWAS for major depressive 111 disorder (MDD) [16] . Heritability for this disorder has been reported to be up to 40% [17] To identify SNP sets that potentially affect common regulatory functions in a cell type 129 specific manner, we need to investigate their genomic location and sequence alterations 130 within so called "functional units". We denote a "functional unit" as a gene-regulatory 131 state of a specific cell type characterized by the mapping of one chromatin feature onto 132 the genome in the absence or presence of additional stimulating/treatment conditions, 133 see ( Figure 1A ). For example, the functional unit "p53-HeLa" was defined by all 134 genomic regions covered by ChIP-seq peaks of the TF p53 within baseline conditions in 135 the HeLa cell line. For this manuscript, the 919 DeepSEA features [12] are considered 136 as functional units representing data from the ENCODE project [13] Next, one kilobase DNA sequences were generated for each SNP for both reference 141 and alternative alleles. We used the pre-trained DeepSEA model [12] to predict the 142 probabilities of a SNP allele to moderate a functional unit. DeepSEA is a method that 143 uses deep neural networks and was trained to predict membership of 919 functional 144 units given a one kilobase genomic sequence. To select SNPs moderating a functional 145 unit, we used the metric provided by DeepSEA that estimates the impact of a variant on 146 the functional read out by comparing the probabilities of allele-specific regulation [12] . 147 Therefore, the authors used one million random SNPs from the 1,000 Genomes project 148 [22] as a background distribution to calculate e-values for each functional unit by 149 assessing the proportion of random variants with a bigger effect than that of the 150 observed variants. SNPs with significant e-values, thus potentially having allele-specific 151 effects on a functional unit, were defined as a functional-unit specific SNP set. In other 152 words, only SNPs with a predicted and significant difference in allele-specific regulatory 153 effect for a given genomic feature in a cell type (functional unit) were retained for the 154 subsequent association analysis. When overlapping the available genotypes (measured 155 and imputed) in the case/control samples with the functional-unit specific SNP sets, 919 156 sets of genotypes filtered by regulatory effect in a functional unit remained for the 157 analysis ( Figure 1B) . 158
For the final step in the DeepWAS, we used the functional genotypes of the case/control 160 sample and possible confounders to associate SNPs set to a disease or trait (Figure  161   1C ). The number of tested SNPs is massively reduced using the above-described 162 functional annotation based on ENCODE data and this variant filtering now enables us 163 to employ regularized regression methods with multiple SNPs. Therefore, each set of 164 regulatory SNPs in one functional unit was subjected to a logistic regression model with 165 L1 regularization (LASSO). In other words, we fitted 919 functional unit-based models to 166 again select regulatory SNPs associated to a trait or disease. For models with at least 167 one non-zero coefficient for a SNP, we further implemented a permutation-based 168 significance test with controlled false positive rate. From all models that withstood this 169 permutation-based multiple testing correction, we finally identified the deepSNPs that 170 are defined as significant non-zero regulatory SNPs associated to the trait or disease 171 and moderating a functional unit. The advantage of DeepWAS over traditional GWAS 172 ( Figure 1D ) is thus twofold, 1) it includes putative regulatory mechanisms in the GWAS 173 analysis from the start and 2) it controls false discovery error by reducing multiple 174 testing. 175
176
DeepWAS of major depressive disorder 177 We used post-quality control genotype data from 1,537 individuals (739 controls and 178 798 cases) of a cohort recruited for recurrent major depressive disorder (MDD). The 179 data were imputed to the 1000 Genomes Phase 1 reference panel [22] using SHAPEIT2 180 [23] and IMPUTE2 [24] . The resulting data set contained more than 1.7 million variantswith MAFs of at least 5% and non-missing genotypes. As expected, a classical GWAS 182 approach failed to identify genome-wide significant associations [16] First, we conducted a methylation quantitative trait locus (meQTL) analysis using whole 248 blood methylation levels of a subset of the recMDD cohort (n=257 individuals). SNP-249
CpG associations were carried out in a 3Mb cis-window around the deepSNPs to 250 assess the effect of nearby CpG sites. From the 26 deepSNPs, we identified 17 251 significant meQTLs containing seven unique deepSNPs (27 %) and 17 CpGs after 252
Bonferroni-correction for all tested CpGs per SNP ( Table 1 ). The majority (>71%) of the 253 meQTL SNPs were associated with more than one DNA methylation site (one to four 254
CpG sites per SNP, Table 1 i.e., showed a significant meta-analysis p-value (see Methods) showing equally or more 263 significant associations than in the discovery cohort alone ( Figure 4D and Table 1) . 264 265 Interestingly, deepSNPs are also associated with MDD-specific methylation changes. In 266 total we found five deepSNP-CpG pairs with significant differences in the allele-specific 267 methylation profiles between MDD cases and controls in recMDD cohort (see Methods). 268
Two of these MDD specific meQTLs are replicated in the independent MPIP cohort (see 269
Additional file 1: Table S1 and Additional file 1: Figure S5) . both bipolar disorder and schizophrenia [30, 31] . 284 285 Finally, we associated the 26 deepSNPs to gene expression directly, by conducting an 286 expression quantitative trait locus (eQTL) analysis using the MPIP cohort data (n=289 287 samples). We examined transcripts within a cis-window of 1.5Mb upstream and 288 downstream of the deepSNPs for an association with whole blood gene expression 289 profiles. We identified three deepSNPs with significant eQTL: rs12541159-MSRA, 290 rs1868881-TIMM10 and rs4646797-ALDH3A2 (Additional file 1: Table S3) . of MSRA were associated with increased cg21290162 methylation ( Figure 5E ). This,motivated us to infer causality and we investigated whether the CpG site could fully 316 explain the observed association between the SNP and MSRA expression using causal 317 inference testing [32] . We found partial mediation of the effect of rs12541159 on MSRA 318 expression by DNA methylation status of CpG site cg21290162 ( Figure 5E , p = 0.043). 319 320 Strikingly, the deepWAS results connected the independently identified six SNPs of the 321 nine molecular QTLs (see Figure 5A ) through a family of TFs, namely MEF2A (myocyte 322 enhancer factor 2A), MEF2C (myocyte enhancer factor 2C) and ATF2 (activating 323 transcription factor 2). Predicted regulatory effect to identical SNPs suggest TF co-324 localization, which has been not been reported so far. We thus utilized ReMap 325 annotation tool [33] to study co-localization and identified a significantly overlap of TF 326
ChIP-seq peaks for these three TFs (Additional file 1: Figure S6 ). Interestingly, a 327 SNP in the locus encompassing the MEF2C gene is the top locus of the largest GWAS 328 for MDD so far, with a p < 10 -16 [19] . Similarly, we identify a regulatory effect of a second 329 TF, P300, of which the respective EB300 gene was a GWAS locus in the discovery 330 cohort [19] . likely not necessary to test all SNPs in GWAS but instead useful to focus on functional 338 annotation to help prioritize putative risk variants [14] . 339
340
In this manuscript, we address this idea by directly integrating the functional data into 341 the GWAS approach itself. To that end, we employed the powerful DeepSEA method 342 [12] that uses raw DNA sequence data to predict regulatory effects of 919 chromatin 343 features (from the ENCODE project) in various cell types, termed "functional unit" here. show promising result [35, 36] . A related multi-SNP approach used pre-clustering of LD 373 blocks prior to LASSO modelling [37] . Models with millions of SNPs are less powerful to 374 associate SNPs, most probably due to the high correlation structure induced by LD. The 375 power of a pre-selection of regulatory SNP sets is underlined by the fact that when all 376 predicted regulatory SNPs (neglecting the information on functional units) were used as 377 input to a single LASSO regression model only one SNP (rs8180478 in osteoblast-378 H2A.Z functional unit) showed significant association with MDD. This is in contrast to 379 the 177 deepSNPs identified using the pre-selection models. 380
381
Currently deepWAS has two main limitations. First, the proposed study was designed 382
for best-guess genotype data (i.e. 0-1-2 encoding). Since LASSO models require fullgenotype information for all samples, the numbers of SNPs entering the analysis had to 384 be reduced due to quality control procedures. To address this issue, we are planning to 385 extend the method for dosage data (i.e. probabilistic representation of genotypes) to 386 increase the range of predicted regulatory effects. This will also necessitate as re-387 evaluation of the LASSO model as many more SNPs in high LD will enter the analysis. 388
The
TNFalpha and glucocorticoids receptor agonist dexamethasone conditions activating 394 NF-κB and GR, respectively [21] . Data from cell lines or bulk tissues will miss variants 395 with effects only in rare cell types or cell type specific effects in native tissue. It is 396 therefore important to be able to retrain the DeepSEA neural network with additional 397 publicly available chromatin features and as well as newly generated experimental data. 398
This will be possible using the deepWAS code publicly available at DOI: 399 10.5281/zenodo.59282. Additional data, from efforts such as the PsychENCODE will 400 make deepWAS even more powerful in the future. 401
402
The power of DeepWAS could be demonstrated in our small GWAS sample for 403 MDD [16] . Only using a subset of SNPs in functionally confined, regulatory units, we 404 identify risk variants for MDD even though the classical GWAS in this small sample was 405 negative (Additional file 1: Figure S1 ). The results in this small MDD sample illustratethe power of deepWAS. 1) DeepSNPs were identified in cell types and enhancers 407 previously shown to be relevant for depression. Furthermore, using the stimulation 408 conditions, the importance of both immune system regulator NF-κB and the 409 glucocorticoid receptor system for depression was also observed in this study. Both 410 systems have been implicated by a large number of previous publications [21, 25, 26] . 2) 411 deepSNPs for MDD were highly likely to be functional in experimental data and impact 412 both DNA methylation and gene expression (Figure 4 and Table 1 , Additional file 1: 413 Table S2 and Table S3 ) as shown by their effects meQTL, eQTL and eQTM analyses. 414
Interestingly, for some of these, differential genotypic effects by major depression status 415
were observed (Additional file 1: Figure S5 and Table S1 found by Barbosa et al [39] . Relating MEF2 to activity-dependent dendritic spine growth 424 and suggesting that this TF may suppress memory formation [39, 40] . Most relevant for 425 this study, SNPs in the locus encoding MEF2C are the top signal in the latest meta-426 analysis for major depression with over 130,000 MDD cases and 310,000 controls [19] 427 and minimum p-value of 9.99*10 -16 . Our study now identified SNPs altering the binding 428 of this TF to target transcript as relevant for MDD. This implies that not only SNPs in the 429 MEF2C locus itself, as seen in the meta-analysis for MDD [19] Triplet of the first three columns together form a functional unit. (XLS) 529
• Cell Line: Name of cell line of the functional unit 530
• Chromatin Feature: Name of chromatin feature of the functional unit 531
• Treatment: Name of Treatment of the cell line of the functional unit 532
• SNP: The deepSNPs jointly associated to MDD using deepWAS 533 • bQTL.alt: Alternative allele base extracted from bQTL study 554
• bQTL.pval: p-value extracted from bQTL study 555
• Higher Binding Allele: Base of higher binding allele extracted from bQTL study 556
• bQTL.TF: Transcription factor extracted from bQTL study 557
• deepwas_TF: Transcription factor identified using MDD deepWAS and rsid 558 http://deepsea.princeton.edu/help/ and the predictions of 1.7M SNPs were generated 607 using NVIDIA GeForce GTX TITAN X GPU (Maxwell) in 10 hours. Next step, filtering of 608 regulatory SNPs, was performed using generated so-called "e-value" files that represent 609 the significance of the regulatory effect of SNPs. We applied an e-value cutoff of 610
!! where we only take the SNPs that are associated to at least one functional unit 611
into consideration e.g. (rs1035271, GM12878, MEF2C). Set of SNPs that have an 612 impact on functional unit is depicted here as set ! . 613
614
We then employed a simple probabilistic genotype encoding where allele-specific 615 regulatory probability of the reference or alternative alleles is used if genotype is 616 reference or alternative homozygous, respectively. If the genotype of the individual is 617 heterozygous then the mean of two allele probabilities are used. Here, we refer to the 618 genotype matrix (1,537 x 1.7M) as where the rows are individuals and columns are 619
SNPs. Genotypes in the matrix is encoded such that !" ∈ {0, 1, 2} where we simply 620 count an arbitrarily chosen allele. We then define as a tensor representing the allele-621 specific probabilities for each SNP, functional unit and allele. For example !"
(!"#) refers 622 to the probability of reference allele of ! in the context of functional unit . Therefore, 623 the SNP encoding scheme can be described in terms of and matrices: 624 The parameters ( ) of the logistic regression are optimized with L1 regularization: 660
where M is the number of individuals, parameter represents the strength of the 662 regularization and vector represents model parameters. We fitted L1-regularized 663 logistic regression model (LASSO) using glmnet R package [42] . Regularization 664 parameter is determined by 100-fold cross validation after which we used 665 "lambda.1se" value to determine non-zero parameters. 666 667 Permutation-based significance test 668
We used a permutation-based approach to select significant LASSO models with non-669 zero coefficients and to control false discovery rate. We generated 1000 random 670 permutations of the response variable and fitted LASSO models on each. parameter 671 in each model is determined by 10-fold cross validation in order to reduce the 672 computational cost. After fitting LASSO models on the permuted data, deviance ratio is 673 used as a test statistic. Top hits were plotted with easyGgplot2 (https://github.com/kassambara/easyGgplot2), 784 corrplot R package [43] and Gviz 1.16.1 bioconductor package [53] . 
Joint analysis 810
For the joint analysis we first measured the overlap of deepSNPs with eQTL, meQTL 811 data and secondly for all overlapping pairs we calculated the overlap of meQTL CpGs 812 and eQTM CpGs. For the deepSNPs, CpG, transcripts triplets we then assessed 813 possible causal relationships by using a causal inference test [32] . 814
The network was plotted using the R package igraph [54] . The triplet was plotted using 815 ggplot2 [55] , corrplot R package [43] and Gviz 1.16.1 Bioconductor package [53] . 
